Nextcure to present at piper sandler 33rd annual virtual healthcare conference

Beltsville, md., nov. 22, 2021 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in the piper sandler virtual 32nd annual healthcare conference on november 30th.
NXTC Ratings Summary
NXTC Quant Ranking